Arterial Pressure in CKD5 - ESRD Population Gérard M. London
|
|
- Roxanne Bond
- 5 years ago
- Views:
Transcription
1 Arterial Pressure in CKD5 - ESRD Population Gérard M. London INSERM U970 Paris
2 150 SBP & DBP by Age, Ethnicity &Gender (US Population Age 18 Years, NHANES III) 150 SBP (mm Hg) Non-Hispanic Black Non-Hispanic White Mexican American SBP (mm Hg) DBP (mm Hg) 70 DBP (mm Hg) SBP (mm Hg) 130 SBP (mm Hg) Pulse pressure 110 Pulse pressure DBP (mm Hg) 70 DBP (mm Hg) 70 Burt VI, et al. Hypertension. 1995;25: Men, Age (y) Women, Age (y)
3 Evolution of Untreated Systolic and Diastolic BP: The Framingham Heart Study. Adapted from Franklin et al. Circulation 1997;96: <120
4 Distribution of Hypertension Subtype in the untreated Hypertensive Population in NHANES III by Age ISH (SBP ³140 mm Hg and DBP <90 mm Hg) SDH (SBP ³140 mm Hg and DBP ³90 mm Hg) IDH (SBP <140 mm Hg and DBP ³90 mm Hg) 100 } Diastolic Hypertension 17% 16% 16% 20% 20% 11% Frequency of hypertension subtypes in all untreated hypertensives (%) < Age (y) Numbers at top of bars represent the overall percentage distribution of untreated hypertension by age. Franklin et al. Hypertension 2001;37:
5 Difference Between SBP and DBP in CHD Prediction, as a Function of Age* 1.0 *Ages 20 to 79 Adjusted for age, sex, & other risk factors + β(sbp) - β(dbp) β(sbp) - β(dbp) = * age (P=0.008) Favor SBP Favor DBP Age (years) Franklin et al. Circulation 2001;103:
6 Hypertension Control by Age Group % Controlled Age <=60 (n=295) Age (n=533) Age >75 (n=361) 20 0 DBP Goal SBP Goal Cross-sectional analysis among 1189 treated hypertensive subjects from Framingham Lloyd-Jones Hypertension 2000;36:594
7 Steep Rise in Pulse Pressure With Increasing Age Data From the Framingham Study Pulse Pressure (mm Hg) Group Data Pulse Pressure (mm Hg) Individual Data <120 Age (y) Age (y) Franklin SS et al. Circulation 1997;96: n=2036
8 Relationship of SBP and DBP to risk for CHD in a dual component model: The Framingham Heart Study CHD hazard ratio SBP 150 mm Hg (P = 0.02) SBP 130 mm Hg (P = 0.06) SBP 110 mm Hg (P = 0.03) Adjusted for age, sex, and other risk factors P = probability for β coefficients DBP (mm Hg) Franklin SS, et al. Circ. 1999;100:354. Mean age = 61 years (range: 50-79), n = 1924
9 Cardiovascular Risk Associated with Increasing SBP at Fixed Values of DBP 2-year risk of endpoint EWPHE (n = 840) SYST-EUR (n = 4695) SYST-CHINA (n = 2394) DBP (mm Hg) SBP (mm Hg) Two-year risk adjusted for active treatment, sex, age, previous CV complications, and smoking by multiple Staessen, et al. Lancet. 2000;355: Cox regression.
10 Blood Pressure and CHD Risk Dual BP Component Models Chi Sq. Hazard Ratio P Value Model 1 SBP ( ) <0.001 DBP ( ) <0.05 Model 2 DBP ( ) NS PP ( ) <0.001 Hazards per 10 mm Hg increment Adjusted for age, sex, smoking, ECG-LVH, BMI, glucose intolerance, total/hdl cholesterol Franklin et al. Circulation 1999;100:354
11 Blood Pressure and Risk for CHD by Age Groups: Results of a Single BP Component Model CHD Hazard Ratio/10 mm Hg (CI) *** SBP (10 mm Hg) DBP (10 mm Hg) *** PP (10 mm Hg) * * *** ** < *** Age (y) Adjusted for age, sex, and other risk factors *P<0.1, **P<0.01, ***P<0.001 Franklin SS, et al. Circulation 2001;103:
12 Evolution of Systolic and Diastolic BP in CKD patients Rohrscheib MP et al CJASN 2008;3:1407
13 Rohrscheib MP et al CJASN 2008;3:1407
14 Klassen PS et a l. JAMA 2002;287: n=37069
15 Liu M et al. NDT 2003; 18:563
16 One Year Mortality for Patients on Hemodialysis predicted by pulse pressure Adjusted for level of systolic blood pressure Hazard Ratio for Death n = 37,069 Predialysis PP Postdialysis PP 4 2 Ref >110 Categories of Pulse Pressure (mmhg) Klassen et al. JAMA 2002;287:
17 Brachial Pulse Pressure and Cardiovascular mortality in ESRD patients Cardiovascular free events Cox model: P=0.033 adjusted for age and mean BP Follow-up (months) PPbr 55 mm Hg P<0.001 PPbr 75 mm Hg NS PPbr 75 mm Hg Safar ME et al Hypertension 2002
18 Common Carotid Pulse Pressure and Cardiovascular mortality in ESRD patients 1.00 Cardiovascular free events PPcc <50 mm Hg PPcc 75 mm Hg PPcc 70 mm Hg Cox model: P= adjusted for age and mean BP P<0.05 P<0.001 P< Follow-up (months) Safar ME et al Hypertension 2002
19 1-year Mortality predicted by SBP Experience at 782 US dialysis facilities n = 37,069 Hazard Ratio for Death Ref Predialysis SBP Postdialysis SBP < > 175 Categories of SBP (mmhg) Klassen et al. JAMA 2002;287:
20 1-year Mortality predicted by DBP Experience at 782 US dialysis facilities Hazard Ratio For Death n = 37,069 Predialysis Postdialysis Adjusted for level of systolic blood pressure > 110 DBP (mmhg) Klassen et al. JAMA 2002;287:
21 Survival curves in hemodialysis patients for each baseline level of diastolic BP 1.0 Baseline d BP (mm Hg) 100+ Proportion surviving Duration of observation, months ISEKI K. et al. Kidney Int 1997
22 Hypertension 2005;45:811
23 All cause mortality according Systolic blood pressure (PAS) N = 5692 P<0.01 Adjusted Cox Z-value 2.23; p= ( ) for 1 mmhg increase Fouque D et al Observatoire National
24 All cause mortality according Diastolic blood pressure (PAd) N = 5692 P<0.01 Adjusted Cox: Z-value = 6.73; p< ( ) for 1 mmhg increase Fouque D. et al Observatoire National
25 Systolic pressure 140 mm Hg Mean BP Pulse pressure 80 Diastolic pressure Mean BP: Cardiac output peripheral resistance Systolic pressure: ventricular ejection (stroke volume and ejection time) arterial stiffness wave reflection Diastolic pressure: arterial resistance arterial Stiffness Diastolic decay time
26 Correlation between arterial pulse pressure, wave reflexion (Augmentation index) aortic pulse wave velocity and stroke volume (n=230) Systolic Pressure (mm Hg) R=0.47 p< Systolice Pressure (mm Hg) R=0.60 p< Augmentation Index (%) Aortic pulse wave velocity (cm/s) Systolic Pressure (mm Hg) R=0.17 P <0.05 London et al KI Stroke volume (ml)
27 Relationship of Resistance, Compliance (C) and Stiffness (S=1/C)with diastolic pressure decay τ-time constant of diastolic decay Blood pressure α-slope of diastolic decay Adapted from Simon et al. Am J Physiol 1979 Blood pressure * τ α.. τ = R.C α =1/τ = 1/R.C α =S/R * log scale Time (sec)
28 Systolic pressure (mm Hg) r = 0.21 P = NS-PWV and SV adjusted Interdialysis body weight changes (kg) Aortic pulse wave velocity-pwv (cm/s) r = 0517 P < Adjust for Systolic BP Age and SV Interdialysis body weight changes (kg) Stroke volume - SV (ml) r = P < 0.01 Adjust. For Systolic BP and PWV Interdialysis body weight changes (kg) London et al Kidney Int 1989
29 Diagrammatic representation of pressure-volume relationships Einc=2 Einc=1 Pressure Mean BP dp/dv Volume
30 ROC Curves of CVdeath Sensitivity Pulse Pressure AUC 72.7±3.2 Aortic PWV AUC 83.4±2.7 Brachial PWV AUC 58.9±3.9 Femoral PWV AUC 56.2± Specificity Pannier B et al Hypertension 2005
31 Correlation between Age and Aortic Pulse Wave Velocity in General population ( ) and ESRD patients ( ) Aortic PWV (m/s) r=0.625 p< Age (years) r=0.719 p< Characteristic impedance (dynes.s.cm-5) r=0.525 P< r=0.340 P< Age (years) Pannier et al Artery 2007;1:78-89
32 Age related changes in arterial internal diameters Carotid artery diameter (mm) Age (years) Brachial artery diameter (mm) Age (years) Controls (r = 0.400; P < 0.01) Controls (r = 0.525;P < 0.01) ESRD (r = 0.438; P < ) ESRD (r = 0.277;P = 0.065) Controls ESRD patients
33 Age related changes in Carotid IMTh Common carotid artery IMTh(mm) Age (years) Controls ESRD patients Pannier et al Hypertension 2005
34 Probability of overall survival in hemodialysis patients according to aortic PWV Probability of overall survival Duration of follow-up (months) PWV < 9.4 m/s 9.4 < PWV < 12.0 m/s PWV > 12.0 m/s Blacher et al. Circulation. 1999
35 All cause survival according to changes in aortic pulse wave velocity (Δ PWV) in response to BP decrease Survival rate Decreased PWV χ 2 = P< Unchanged or PWV Duration of follow-up (months) Guérin et al. Circulation
36 Changes of mean blood pressure and aortic PWV MBP (mmhg) PWV (m/s) MBP (mmhg) PWV (m/s) Inclusion At target BP End of follow up Inclusion At target BP End of follow up Survivors Non Survivors Guérin and al. circulation 2001 ; 103 :
37 ROC Curve of CV mortality Sensitivity Criterions Age; AUC 72±5% Pulse Pressure; AUC 72±5% Carotid IMT;AUC 68±6% LVmassix; AUC 72±5% 0.25 Calcification score; AUC 82±4% Aortic PWV; AUC 82±4% Specificity PWV 2 = Einc x arterial IMT/arterial radius wher Einc is incremental elastic modulus London et al. Cur Op hypertens Nephrol 2006
38 Schematic representation of reactive hyperemic response in the human forearm after five minutes of ischemia Forearm blood flow ml/100 ml/min * * * * * * A = Flow debt ml/100 ml Peak flow * * * Flow debt repayment=b/a B = Excess hyperemic flow ml/100ml Duration of hyperemia * * * * * * * * * * * * * * * * baseline occlusion postocclusion Time,min
39 P< P< Flow debt repayment (%) Controls ESRD Time to debt repayment (s) Controls ESRD Pannier B et al. Kidney Int 2001
40 Probability of survival in ESRD patients according to postischemic forearm flow debt repayement (FDR) 1.00 Survivorship χ²=17.9 P< Follow-up (months) FDR>85% FDR<85% London GM et al. Kidney Int 2003
41 Methods of stimulating increased blood flow Mullen, M. J. et al. Circ Res 2001;88:
42 Echotracking is 3 to 10 x more precise than image based techniques Signal averaging RF lines IMT Spatial resolution 2 D TM RF Signal µm µm
43 Graphs show FMD, GTN-induced dilation, and RH in normotensive subjects (white circles and bars) and in patients with essential hypertension (black circles and bars) Ghiadoni, L. et al. Hypertension 2003;41:
44 Traub, O. et al. Arterioscler Thromb Vasc Biol 1998;18: Endothelial cell biology and shear stress
45 Brachial artery characteristics Controls ESRD Baseline BA diameter (mm) 4.12 ± ± 0.11 < 0.01 BA compliance (m 2 1.kPa.10 7 ) 0.45 ± ± 0.02 < BA distensibility (kpa.10 3 ) 3.5 ± ± 0.19 < BA incremental elastic modulus (kpa.10 ) 3.0 ± ± 0.42 < BA circumferential wall stress (kpa) 60 ± ± 1.9 NS Baseline mean flow velocity (cm/s) 4.6 ± ± 0.30 < 0.01 Baseline mean flow (ml/min) 39 ± ± 3.6 NS Baseline mean SR (s- 1 ) 1 Baseline peak SR (s-) 53 ± ± 3.5 < ± ± 26 < 0.05 Whole blood viscosity (cpoise) 3.57 ± ± 0.06 < Baseline mean SS (dynes/cm²) 19 ± ± 1.0 < Baseline peak SS (dynes/cm²) 129 ± 9 83 ± 5 < Verbeke et al JASN 2007
46 Relationship in Controls and ESRD patients between brachial artery (BA) diameter and compliance and BA shear stress Verbeke et al JASN 2007
47 TNT-Δ Brachial artery diameter (%) Controls P < 0.05 ESRD TNT-MD (% from baseline) Brachial artery distensibility (kpa10-3) Verbeke et al. JASN 2007
48
Pathophysiology of Vascular Function in CKD. INSERM U970 Hôpital Européen Georges Pompidou Paris
Pathophysiology of Vascular Function in CKD Gérard M. London INSERM U970 Hôpital Européen Georges Pompidou Paris Arterial Pathophysiology and Cardiovascular Diseases in CKD Systolic BP; Diastolic BP Arteriosclerosis
More informationArterial Stiffness: pathophysiology and clinical impact. Gérard M. LONDON Manhès Hospital Fleury-Mérogis/Paris, France
Arterial Stiffness: pathophysiology and clinical impact Gérard M. LONDON Manhès Hospital Fleury-Mérogis/Paris, France Determinants of vascular overload (afterload) on the heart Peripheral Resistance Arterial
More informationHTA ET DIALYSE DR ALAIN GUERIN
HTA ET DIALYSE DR ALAIN GUERIN Cardiovascular Disease Mortality General Population vs ESRD Dialysis Patients 100 Annual CVD Mortality (%) 10 1 0.1 0.01 0.001 25-34 35-44 45-54 55-64 66-74 75-84 >85 Age
More informationAssessment of Arterials Functions: Is Pulse Wave Velocity ready forprime Time. Gérard M. LONDON INSERM U970 Hopital Georges Pompidou Paris, France
Assessment of Arterials Functions: Is Pulse Wave Velocity ready forprime Time Gérard M. LONDON INSERM U970 Hopital Georges Pompidou Paris, France The causes of Cardiovascular Diseases in CKD Systolic BP;
More informationEffects of Renin-Angiotensin System blockade on arterial stiffness and function. Gérard M. LONDON Manhès Hospital Paris, France
Effects of Renin-Angiotensin System blockade on arterial stiffness and function Gérard M. LONDON Manhès Hospital Paris, France Determinants of vascular overload (afterload) on the heart Peripheral Resistance
More informationTargeting vascular damage (stiffness, calcifications) in CKD: beyond blood pressure
Targeting vascular damage (stiffness, calcifications) in CKD: beyond blood pressure Should we still measure BP in dialysis? Clinical Problems with cuff BP Case #1: Variances in Cuff BP vs. Central BP 140/80
More informationCardiovascular Diseases in CKD
1 Cardiovascular Diseases in CKD Hung-Chun Chen, MD, PhD. Kaohsiung Medical University Taiwan Society of Nephrology 1 2 High Prevalence of CVD in CKD & ESRD Foley RN et al, AJKD 1998; 32(suppl 3):S112-9
More informationDirector of the Israeli Institute for Quality in Medicine Israeli Medical Association July 1st, 2016
The differential effect of Atherosclerosis on end organ damage in adult and elderly patients with CVRF: New Algorithm for Hypertension Diagnosis and Treatment R. Zimlichman, FAHA, FASH, FESC, FESH Chief
More informationWhich method is better to measure arterial stiffness; augmentation index, pulse wave velocity, carotid distensibility? 전북의대내과 김원호
Which method is better to measure arterial stiffness; augmentation index, pulse wave velocity, carotid distensibility? 전북의대내과 김원호 Arterial stiffness Arterial stiffness is inversely related to arterial
More informationCoronary artery disease (CAD) risk factors
Background Coronary artery disease (CAD) risk factors CAD Risk factors Hypertension Insulin resistance /diabetes Dyslipidemia Smoking /Obesity Male gender/ Old age Atherosclerosis Arterial stiffness precedes
More informationNomogram of the Relation of Brachial-Ankle Pulse Wave Velocity with Blood Pressure
801 Original Article Nomogram of the Relation of Brachial-Ankle Pulse Wave Velocity with Blood Pressure Akira YAMASHINA, Hirofumi TOMIYAMA, Tomio ARAI, Yutaka KOJI, Minoru YAMBE, Hiroaki MOTOBE, Zydem
More informationTheoretical and practical questions in the evaluation of arterial function Miklós Illyés MD. Ph.D.
Theoretical and practical questions in the evaluation of arterial function Miklós Illyés MD. Ph.D. TensioMed Arterial Stiffness Centre, Budapest Heart Institute, Faculty of Medicine, University of Pécs
More informationWhen should you treat blood pressure in the young?
ESC Stockholm - Dilemmas in Cardiovascular Disease Prevention in the Young: 30 th August 2010 When should you treat blood pressure in the young? Bryan Williams MD FRCP FAHA FESC Professor of Medicine Department
More informationUniversity of Padova, Padua, Italy, and HARVEST Study Group, Italy
University of Padova, Padua, Italy, and HARVEST Study Group, Italy ISOLATED SYSTOLIC HYPERTENSION IN THE YOUNG DOES NOT IMPLY AN INCREASED RISK OF FUTURE HYPERTENSION NEEDING TREATMENT Mos L, Saladini
More informationIsolated Systolic Hypertension in the elderly. Daniel Hayoz Clinique de Médecine Interne HFR-Hôpital Cantonal Fribourg
Isolated Systolic Hypertension in the elderly Daniel Hayoz Clinique de Médecine Interne HFR-Hôpital Cantonal Fribourg Case no 1 Man aged 75, from Kosovo, in CH since 1.5 years Former smoker (45 PY) BP:
More informationBenefits from angiotensin-converting enzyme inhibition in patients with renal failure: latest results
European Heart Journal Supplements (2003) 5 (Supplement E), E18 E22 Benefits from angiotensin-converting enzyme inhibition in patients with renal failure: latest results B. Pannier, A.P. Guérin, S.J. Marchais
More informationClinical application of Arterial stiffness. pulse wave analysis pulse wave velocity
Clinical application of Arterial stiffness pulse wave analysis pulse wave velocity Arterial system 1. Large arteries: elastic arteries Aorta, carotid, iliac, Buffering reserve: store blood during systole
More informationEndothelial function is impaired in women who had pre-eclampsia
Endothelial function is impaired in women who had pre-eclampsia Christian Delles, Catriona E Brown, Joanne Flynn, David M Carty Institute of Cardiovascular and Medical Sciences University of Glasgow United
More informationDepartments of Cardiology and Vascular Surgery Michaelidion Cardiac Center University of Ioannina, Greece
Departments of Cardiology and Vascular Surgery Michaelidion Cardiac Center University of Ioannina, Greece ARGYRIS Vassilis, PEROULIS Michalis, MATSAGKAS Miltiadis, BECHLIOULIS Aris, MICHALIS Lampros, NAKA
More informationT. Suithichaiyakul Cardiomed Chula
T. Suithichaiyakul Cardiomed Chula The cardiovascular (CV) continuum: role of risk factors Endothelial Dysfunction Atherosclerosis and left ventricular hypertrophy Myocardial infarction & stroke Endothelial
More informationAllopurinol reduces left ventricular hypertrophy and endothelial dysfunction in patients with chronic kidney disease
Allopurinol reduces left ventricular hypertrophy and endothelial dysfunction in patients with chronic kidney disease Michelle P Kao, Donald S Ang, Steve Gandy, Chim C Lang, Allan D Struthers Division of
More informationCan Arterial Stiffness Be Reversed? And If So, What Are the Benefits?
...SYMPOSIUM PROCEEDINGS... Can Arterial Stiffness Be Reversed? And If So, What Are the Benefits? Based on a presentation by Michel E. Safar, MD Presentation Summary Systolic and diastolic blood pressure
More informationDanno d organo bersaglio e rischio CV. Persiste un ruolo prognostico oltre la patologia d organo?
Danno d organo bersaglio e rischio CV. Persiste un ruolo prognostico oltre la patologia d organo? Prof. Massimo Salvetti Clinica Medica University of Brescia Percieved risk Actual risk Sehestedt et al,
More information1. Albuminuria an early sign of glomerular damage and renal disease. albuminuria
1. Albuminuria an early sign of glomerular damage and renal disease albuminuria Cardio-renal continuum REGRESS Target organ damage Asymptomatic CKD New risk factors Atherosclerosis Target organ damage
More informationCentral pressures and prediction of cardiovascular events in erectile dysfunction patients
Central pressures and prediction of cardiovascular events in erectile dysfunction patients N. Ioakeimidis, K. Rokkas, A. Angelis, Z. Kratiras, M. Abdelrasoul, C. Georgakopoulos, D. Terentes-Printzios,
More informationBlood Pressure Response Under Chronic Antihypertensive Drug Therapy
Journal of the American College of Cardiology Vol. 53, No. 5, 29 29 by the American College of Cardiology Foundation ISSN 735-197/9/$36. Published by Elsevier Inc. doi:1.116/j.jacc.28.9.46 Hypertension
More informationD Terentes-Printzios, C Vlachopoulos, G Vyssoulis, N Ioakeimidis, P Xaplanteris, K Aznaouridis, E Christoforatou, A Samentzas, A Siama, C Stefanadis
Peripheral Vessels Unit, 1st Department of Cardiology Athens Medical School Hippokration Hospital, Athens, Greece D Terentes-Printzios, C Vlachopoulos, G Vyssoulis, N Ioakeimidis, P Xaplanteris, K Aznaouridis,
More informationLeft ventricular hypertrophy: why does it happen?
Nephrol Dial Transplant (2003) 18 [Suppl 8]: viii2 viii6 DOI: 10.1093/ndt/gfg1083 Left ventricular hypertrophy: why does it happen? Gerard M. London Department of Nephrology and Dialysis, Manhes Hospital,
More informationRelationship between Arterial Stiffness and the Risk of Coronary Artery Disease in Subjects with and without Metabolic Syndrome
243 Original Article Hypertens Res Vol.30 (2007) No.3 p.243-247 Relationship between Arterial Stiffness and the Risk of Coronary Artery Disease in Subjects with and without Metabolic Syndrome Yutaka KOJI
More informationDiastolic hypertension, defined as a diastolic blood pressure
Hypertension Predictors of New-Onset Diastolic and Systolic Hypertension The Framingham Heart Study Stanley S. Franklin, MD; Jose R. Pio, BS; Nathan D. Wong, PhD; Martin G. Larson, ScD; Eric P. Leip, MS;
More informationOptimal blood pressure targets in chronic kidney disease
Optimal blood pressure targets in chronic kidney disease Pr. Michel Burnier Service of Nephrology and Hypertension University Hospital Lausanne Switzerland Evidence-Based Guideline for the Management
More informationΗ σημασία της αρτηριακής σκληρίας στην εκτίμηση της διαστολικής δυσλειτουργίας στην υπέρταση. Θεραπευτικές παρεμβάσεις
Η σημασία της αρτηριακής σκληρίας στην εκτίμηση της διαστολικής δυσλειτουργίας στην υπέρταση. Θεραπευτικές παρεμβάσεις Ελένη Τριανταφυλλίδη Επιμελήτρια Α Β Πανεπιστημιακή Καρδιολογική Κλινική Αττικό Νοσοκομείο
More informationHow clinically important are the results of the large trials in hypertension?
How clinically important are the results of the large trials in hypertension? Stéphane LAURENT, MD, PhD, FESC Pharmacology Department and PARCC / INSERM U970 Hôpital Européen Georges Pompidou, Université
More informationCentral Pressures and Prehypertension
Central Pressures and Prehypertension Charalambos Vlachopoulos Associate Professor of Cardiology 1 st Cardiology Dept Athens Medical School Central Pressures and Prehypertension Charalambos Vlachopoulos
More informationHYPERTENSION AND HEART FAILURE
HYPERTENSION AND HEART FAILURE Kenya Cardiac Society Symposium Feb 2017 Dr Jeilan Mohamed No conflict of interests . Geoffrey, 45 yr old hypertensive office worker male from Nairobi, has just watched his
More informationArterial stiffness and central BP as goals for antihypertensive therapy in pre- and elderly. Piotr Jankowski
Arterial stiffness and central BP as goals for antihypertensive therapy in pre- and elderly Piotr Jankowski I Department of Cardiology and Hypertension CM UJ, Kraków, Poland piotrjankowski@interia.pl Vienna,
More informationCl inical Study of Arterial Buffering Function and Endothel ial Function in Patients with Essential Hypertension
48 (200025) 54 16 ( Pulse wave velocity PWV) - PWV(CPWV) (Distensibility) (CSC) (VD) CPWV ( P = 0. 0483) CSC VD ( P = 0. 0302 P = 0. 0196) ( P = 0. 0130) VD ( r = 0. 3995 P = 0. 0011) Cl inical Study of
More informationSpecial Lecture 10/28/2012
Special Lecture 10/28/2012 HYPERTENSION Dr. HN Mayrovitz Special Lecture 10/28/2012 Arterial Blood Pressure (ABP) - Definitions ABP Review Indirect Oscillographic Method Resistance (R), Compliance (C)
More informationDiverse Techniques to Detect Arterial Stiffness
Diverse Techniques to Detect Arterial Stiffness 백상홍가톨릭대학교강남성모병원순환기내과 혈관연구회창립심포지움 2005, 3, 3 Small Arteries Arterial Remodelling Thickness Internal diameter Wall / Lumen Large Arteries Cross sectional
More informationArterial function and longevity Focus on the aorta
Arterial function and longevity Focus on the aorta Panagiota Pietri, MD, PhD, FESC Director of Hypertension Unit Athens Medical Center Athens, Greece Secrets of longevity Secrets of longevity Unveiling
More informationDetermination of age-related increases in large artery stiffness by digital pulse contour analysis
Clinical Science (2002) 103, 371 377 (Printed in Great Britain) 371 Determination of age-related increases in large artery stiffness by digital pulse contour analysis S. C. MILLASSEAU, R. P. KELLY, J.
More informationSummary. Introduction
Clin Physiol Funct Imaging (2008) doi: 10.1111/j.1475-097X.2008.00816.x 1 Arterial compliance and endothelium-dependent vasodilation are independently related to coronary risk in the elderly: the Prospective
More information3 Aging, Arterial Stiffness,
Chapter 3 / Mechanisms of Hypertension 23 3 Aging, Arterial Stiffness, and Systolic Hypertension Joseph L. Izzo, Jr., MD CONTENTS INTRODUCTION POPULATION STUDIES PATHOPHYSIOLOGY NONINVASIVE MEASUREMENT
More informationKDOQI Guidelines. Overview. Predicting Successful Fistula Maturation Warren Gasper MD UCSF Vascular Surgery Fellow 2011 UCSF Vascular Symposium
DISCLOSURES: NONE Predicting Successful Fistula Maturation Warren Gasper MD UCSF Vascular Surgery Fellow 2011 UCSF Vascular Symposium KDOQI Guidelines AV fistulas have better outcomes than grafts or catheters
More informationVascular disease. Structural evaluation of vascular disease. Goo-Yeong Cho, MD, PhD Seoul National University Bundang Hospital
Vascular disease. Structural evaluation of vascular disease Goo-Yeong Cho, MD, PhD Seoul National University Bundang Hospital resistance vessels : arteries
More informationCoronary artery calcification and aortic pulse wave velocity in chronic kidney disease patients
Kidney International, Vol. 65 (2004), pp. 1790 1794 Coronary artery calcification and aortic pulse wave velocity in chronic kidney disease patients ALI A. HAYDAR, ADRIAN COVIC, HELEN COLHOUN, MICHAEL RUBENS,
More informationIS PVR THE RIGHT METRIC FOR RV AFTERLOAD?
Echo Doppler Assessment of PVR The Children s Hospital Denver, CO Robin Shandas Professor of Pediatrics, Cardiology Professor of Mechanical Engineering Director, Center for Bioengineering University of
More informationBackground. Metabolic syndrome T2DM CARDIOVASCULAR DISEASE. Major Unmet Clinical Need. Novel Risk Factors. Classical Risk Factors LDL-C.
The effect of metabolic syndrome for left ventricular geometry, arterial stiffness and carotid intima-media thickness in Korean general population Result from Atherosclerosis RIsk of Rural Area in Korea
More informationARTERIAL STIFFNESS ASSESSMENT COMMENTS:
ARTERIAL STIFFNESS ASSESSMENT 10% Low small artery stiffness risk. However, we detect mild vasoconstriction in small artery. No large arterial stiffness has been detected. High Blood Pressure & Arterial
More informationPongamorn Bunnag, MD Boonsong Ongphiphadhanakul, MD. Mahidol University
Roles oesof Fetuin-A in Hypertension Pongamorn Bunnag, MD Boonsong Ongphiphadhanakul, MD Ramathibodi Hospital Mahidol University Fetuin-A (Alpha-2-HS-glycoprotein) Multi-functional protein secreted by
More informationEstimated Pulse Wave Velocity Calculated from Age and Mean Arterial Blood Pressure
Received: August 19, 2016 Accepted after revision: November 4, 2016 Published online: December 1, 2016 2235 8676/16/0044 0175$39.50/0 Mini-Review Estimated Pulse Wave Velocity Calculated from Age and Mean
More informationManaging HTN in the Elderly: How Low to Go
Managing HTN in the Elderly: How Low to Go Laxmi S. Mehta, MD, FACC The Ohio State University Medical Center Assistant Professor of Clinical Internal Medicine Clinical Director of the Women s Cardiovascular
More informationMeasurement and Analysis of Radial Artery Blood Velocity in Young Normotensive Subjects
Informatica Medica Slovenica 2003; 8(1) 15 Research Paper Measurement and Analysis of Radial Artery Blood in Young Normotensive Subjects Damjan Oseli, Iztok Lebar Bajec, Matjaž Klemenc, Nikolaj Zimic Abstract.
More informationDeterminants of Accelerated Progression of Arterial Stiffness in Normotensive Subjects and in Treated Hypertensive Subjects Over a 6-Year Period
Determinants of Accelerated Progression of Arterial Stiffness in Normotensive and in Treated Hypertensive Over a 6-Year Period Athanase Benetos, MD, PhD; Chris Adamopoulos, MD; Jeanne-Marie Bureau, MD;
More informationVarious Indices of Arterial Stiffness: Are They Closely Related or Distinctly Different?
Received: October 19, 2016 Accepted after revision: February 8, 2017 Published online: April 7, 2017 Mini-Review Various Indices of Arterial Stiffness: Are They Closely Related or Distinctly Hirofumi Tanaka
More informationPreventing heart disease by controlling hypertension: Impact of hypertensive subtype, stage, age, and sex
Prevention and Rehabilitation Preventing heart disease by controlling hypertension: Impact of hypertensive subtype, stage, age, and sex Nathan D. Wong, PhD, a Gaurav Thakral, BS, a Stanley S. Franklin,
More informationRole of imaging in risk assessment models: the example of CIMT
Role of imaging in risk assessment models: the example of CIMT Diederick E. Grobbee, MD, PhD, FESC Professor of Clinical Epidemiology Julius Center for Health Sciences and Primary Care, University Medical
More informationCauses of Poor BP control Rates
Goals Of Hypertension Management in Clinical Practice World Hypertension League (WHL) Meeting Adel E. Berbari, MD, FAHA, FACP Professor of Medicine and Physiology Head, Division of Hypertension and Vascular
More informationArterial stiffness index: A new evaluation for arterial stiffness in elderly patients with essential hypertension
Blackwell Science, LtdOxford, UK GGIGeriatrics and Gerontology International1444-15862002 Blackwell Science Asia Pty Ltd 24December 2002 045 ASI in elderly hypertensive patients M Kaibe et al. 10.1046/j.1444-1586.2002.00045.x
More informationΠρώιμη αγγειακή γήρανση στην υπέρταση: διάγνωση και αντιμετώπιση
Πρώιμη αγγειακή γήρανση στην υπέρταση: διάγνωση και αντιμετώπιση Χαράλαμπος Βλαχόπουλος 1 η Καρδιολογική Κλινική Πανεπιστημίου Αθηνών Ιπποκράτειο Γ.Ν.Α. Οι προβλεπόμενες αρτηριακές αλλαγές με βάση την
More informationMechanisms of heart failure with normal EF Arterial stiffness and ventricular-arterial coupling. What is the pathophysiology at presentation?
Mechanisms of heart failure with normal EF Arterial stiffness and ventricular-arterial coupling What is the pathophysiology at presentation? Ventricular-arterial coupling elastance Central arterial pressure
More informationMeasurement of Arterial Stiffness: Why should I measure both PWA and PWV?
Measurement of Arterial Stiffness: Why should I measure both PWA and PWV? Central blood pressure and measures of arterial stiffness have been shown to be powerful predictors of major cardiovascular events,
More informationPHENOTYPING FAMILIES OF A HYPERTENSIVE PATIENT
PHENOTYPING FAMILIES OF A HYPERTENSIVE PATIENT Christian Delles BHF Glasgow Cardiovascular Research Centre Advantages Cardiovascular of a Family-based ContinuumDesign Related subjects are more likely to
More informationCVD risk assessment using risk scores in primary and secondary prevention
CVD risk assessment using risk scores in primary and secondary prevention Raul D. Santos MD, PhD Heart Institute-InCor University of Sao Paulo Brazil Disclosure Honoraria for consulting and speaker activities
More informationTitle. CitationTransplantation Proceedings, 44(3): Issue Date Doc URL. Type. File Information
Title Successful Kidney Transplantation Ameliorates Arteri Hotta, Kiyohiko; Harada, Hiroshi; Sasaki, Hajime; Iw Author(s) Togashi, Masaki; Nonomura, Katsuya CitationTransplantation Proceedings, 44(3):
More informationThe arterial system has a dual function:
Hellenic J Cardiol 2010; 51: 385-390 Editorial Aortic Stiffness: Prime Time for Integration into Clinical Practice? Charalambos Vlachopoulos, Nikolaos Alexopoulos, Christodoulos Stefanadis Peripheral Vessels
More informationAn Epidemiological Overview
An Epidemiological Overview Cardiovascular disease (CVD) is the leading cause of death in the U.S. In 2005 CVD accounted for approximately 38 percent of all deaths CVD has been the number one killer in
More informationASSOCIATION OF SYSTEMIC INFLAMMATION WITH ARTERIAL STIFFNESS IN HYPERTENSION
ASSOCIATION OF SYSTEMIC INFLAMMATION WITH ARTERIAL STIFFNESS IN HYPERTENSION Jung-Sun Kim a and Sungha Park a,b, a Division of Cardiology, b Cardiovascular Genome Center, Yonsei Cardiovascular Center,
More informationImpact de la convection
Dysfonction Endothéliale, et toxines urémiques des patients dialysés Impact de la convection Ziad A. Massy Ambroise Paré Hospital, University Hospitals Paris Ile de France West, UVSQ, Boulogne Billancourt
More informationImpedance Cardiography (ICG) Application of ICG for Hypertension Management
Application of ICG for Hypertension Management 1mA @ 100 khz Impedance Cardiography (ICG) Non-invasive Beat-to-beat Hemodynamic Monitoring Diastole Systole Aortic valve is closed No blood flow in the aorta
More informationAntihypertensive Trial Design ALLHAT
1 U.S. Department of Health and Human Services Major Outcomes in High Risk Hypertensive Patients Randomized to Angiotensin-Converting Enzyme Inhibitor or Calcium Channel Blocker vs Diuretic National Institutes
More informationA comparison of diabetic and nondiabetic subjects
Pathophysiology/Complications O R I G I N A L A R T I C L E The Aging of Elastic and Muscular Arteries A comparison of diabetic and nondiabetic subjects JAMES D. CAMERON, MD, MENGSC 1 CHRISTOPHER J. BULPITT,
More informationThe Multiethnic Study of Atherosclerosis (MESA) Cardiovascular Risk in Hispanics
The Multiethnic Study of Atherosclerosis (MESA) Cardiovascular Risk in Hispanics Michael H. Criqui MD, MPH Distinguished Professor and Chief, Division of Preventive Medicine Department of Family and Preventive
More informationThe Study of Aortic Stiffness in Different Hypertension Subtypes in Dialysis Patients
593 Original Article Hypertens Res Vol.31 (2008) No.4 p.593-599 The Study of Aortic Stiffness in Different Hypertension Subtypes in Dialysis Patients Li-Tao CHENG 1),2), Hui-Min CHEN 1),3), Li-Jun TANG
More informationSpecial Lecture 11/08/2013. Hypertension Dr. HN Mayrovitz
Special Lecture 11/08/2013 Hypertension Dr. HN Mayrovitz Arterial Blood Pressure (ABP) Major Factors Summarized Sympathetic Hormones Arteriole MAP ~ Q x TPR + f (V / C) SV x HR Renal SBP Hypertension =
More informationEarly Detection of Damaged Organ
Early Detection of Damaged Organ Regional Cardiovascular Center, Chungbuk National University Kyung-Kuk Hwang Contents NICE guideline 2011 - Confirm the diagnosis of HT ambulatory blood pressure monitoring
More informationEpidemiological and clinical studies have shown that
Impact of Aortic Stiffness Attenuation on Survival of Patients in End-Stage Renal Failure Alain P. Guerin, MD; Jacques Blacher, MD, PhD; Bruno Pannier, MD; Sylvain J. Marchais, MD; Michel E. Safar, MD;
More informationThe Study of Endothelial Function in CKD and ESRD
The Study of Endothelial Function in CKD and ESRD Endothelial Diversity in the Human Body Aird WC. Circ Res 2007 Endothelial Diversity in the Human Body The endothelium should be viewed for what it is:
More informationTechniques of Vital Signs. John Gazewood, MD, MSPH Department of Family Medicine
Techniques of Vital Signs John Gazewood, MD, MSPH Department of Family Medicine Objectives Define normal in several ways. Describe correct technique of measuring vital signs. Describe correct technique
More informationPrevention of Atrial Fibrillation and Heart Failure in the Hypertensive Patient
Prevention of Atrial Fibrillation and Heart Failure in the Hypertensive Patient The Issue of Primary Prevention of A.Fib. (and Heart Failure) and not the Prevention of Recurrent A.Fib. after Electroconversion
More informationALLHAT Role of Diuretics in the Prevention of Heart Failure - The Antihypertensive and Lipid- Lowering Treatment to Prevent Heart Attack Trial
1 ALLHAT Role of Diuretics in the Prevention of Heart Failure - The Antihypertensive and Lipid- Lowering Treatment to Prevent Heart Attack Trial Davis BR, Piller LB, Cutler JA, et al. Circulation 2006.113:2201-2210.
More informationΜαρία Μαρκέτου Επιμ. Α Καρδιολογική Κλινική ΠαΓΝΗ
Μαρία Μαρκέτου Επιμ. Α Καρδιολογική Κλινική ΠαΓΝΗ Ischemic Heart Disease Mortality Rate in Each Decade of Age IHD mortality (floating absolute risk and 95% CI) 256 128 64 32 16 8 4 2 SBP 256 128 64 32
More informationChoosing Study Outcomes that Reflect Cardiovascular Disease: From Biomarkers to Burden of Disease. Greg Wellenius Joel Kaufman
Choosing Study Outcomes that Reflect Cardiovascular Disease: From Biomarkers to Burden of Disease Greg Wellenius Joel Kaufman Framework for Choosing Subclinical Outcomes To Study What clinical outcomes
More informationJ-curve Revisited. An Analysis of Blood Pressure and Cardiovascular Events in the Treating to New Targets (TNT) Trial
J-curve Revisited An Analysis of Blood Pressure and Cardiovascular Events in the Treating to New Targets (TNT) Trial Sripal Bangalore, MD, MHA, Franz H Messerli, MD, Chuan-Chuan Wun, PhD, Andrea L. Zuckerman,
More informationEffects of Kidney Disease on Cardiovascular Morbidity and Mortality
Effects of Kidney Disease on Cardiovascular Morbidity and Mortality Joachim H. Ix, MD, MAS Assistant Professor in Residence Division of Nephrology University of California San Diego, and Veterans Affairs
More informationMaher Fouad Ramzy; MD, FACP Professor of Renal Medicine, Cairo University
Hypertension in Hemodialysis Patient Maher Fouad Ramzy; MD, FACP Professor of Renal Medicine, Cairo University Mechanism of HTN in HD patients Volume-dependent HTN ECV expansion. Volume-independent HTN
More informationBrachial artery hyperaemic blood flow velocity and left ventricular geometry
(2011), 1 5 & 2011 Macmillan Publishers Limited All rights reserved 0950-9240/11 www.nature.com/jhh ORIGINAL ARTICLE Brachial artery hyperaemic blood flow velocity and left ventricular geometry SJ Järhult,
More informationINTERNATIONAL REGISTRY FOR AMBULATORY BLOOD PRESSURE AND ARTERIAL STIFFNESS TELEMONITORING
INTERNATIONAL REGISTRY FOR AMBULATORY BLOOD PRESSURE AND ARTERIAL STIFFNESS TELEMONITORING VASOTENS Registry Vascular health ASsessment Of The hypertensive patients Project Coordinator: Dr. Stefano Omboni
More information47 Hypertension in Elderly
47 Hypertension in Elderly YOU DO NOT HEAL OLD AGE; YOU PROTECT IT; YOU PROMOTE IT; YOU EXTEND IT Sir James Sterling Ross Abstract: The prevalence of hypertension rises with age and the complications secondary
More informationPreventing Early Vascular Ageing (EVA) and its hemodynamic changes
Translational Research 31 st October 2013, Moscow Preventing Early Vascular Ageing (EVA) and its hemodynamic changes Peter M Nilsson, MD, PhD Department of Clinical Sciences Lund University University
More informationThe monthly ESH guide through publications
NEWSLETTER APRIL 2016 The monthly ESH guide through publications Edited by: Prof Costas Tsioufis, ESH Secretary and Dr Alex Kasiakogias Effects of hypertension treatment on heart failure: insights from
More informationHypertension in the Elderly. John Puxty Division of Geriatrics Center for Studies in Aging and Health, Providence Care
Hypertension in the Elderly John Puxty Division of Geriatrics Center for Studies in Aging and Health, Providence Care Learning Objectives Review evidence for treatment of hypertension in elderly Consider
More informationHypertension: What s new since JNC 7. Harold M. Szerlip, MD, FACP, FCCP, FASN, FNKF
Hypertension: What s new since JNC 7 Harold M. Szerlip, MD, FACP, FCCP, FASN, FNKF Disclosures Spectral Diagnostics Site investigator Eli Lilly Site investigator ACP IM ITE writing committee NBME Step
More informationPulse wave velocity, augmentation index and arterial age in students
Pulse wave velocity, augmentation index and arterial age in students IOANA MOZOS 1, SERBAN GLIGOR 2 1 Department of Functional Sciences Victor Babes University of Medicine and Pharmacy Timisoara ROMANIA
More informationJournal of the American College of Cardiology Vol. 51, No. 14, by the American College of Cardiology Foundation ISSN /08/$34.
Journal of the American College of Cardiology Vol. 51, No. 14, 2008 2008 by the American College of Cardiology Foundation ISSN 0735-1097/08/$34.00 Published by Elsevier Inc. doi:10.1016/j.jacc.2007.10.065
More informationsurtout qui n est PAS à risque?
3*25 min et surtout qui n est PAS à risque? 2018 ESC/ESH Hypertension Guidelines 2018 ESC-ESH Guidelines for the Management of Arterial Hypertension 28 th ESH Meeting on Hypertension and Cardiovascular
More informationFondazione C.N.R./Regione Toscana G. Monasterio Pisa - Italy. Imaging: tool or toy? Aortic Compliance
Fondazione C.N.R./Regione Toscana G. Monasterio Pisa - Italy massimo lombardi Imaging: tool or toy? Aortic Compliance 2011 ESC Paris Disclosure: Cardiovascular MR Unit is receiving research fundings from
More informationBlood Pressure Monitoring in Chronic Kidney Disease
Blood Pressure Monitoring in Chronic Kidney Disease Aldo J. Peixoto, MD FASN FASH Associate Professor of Medicine (Nephrology), YSM Associate Chief of Medicine, VACT Director of Hypertension, VACT American
More informationAn Epidemiological Overview
An Epidemiological Overview Cardiovascular disease (CVD) is the leading cause of death in the U.S. In 2005 CVD accounted for approximately 38 percent of all deaths CVD has been the number one killer in
More information